Advertisement
Canada markets open in 1 hour 12 minutes

  • S&P/TSX

    21,516.90
    -94.40 (-0.44%)
     

  • S&P 500

    5,487.03
    +13.80 (+0.25%)
     

  • DOW

    38,834.86
    +56.76 (+0.15%)
     

  • CAD/USD

    0.7294
    -0.0003 (-0.05%)
     

  • CRUDE OIL

    81.59
    +0.02 (+0.02%)
     

  • Bitcoin CAD

    90,525.62
    +1,290.88 (+1.45%)
     

  • CMC Crypto 200

    1,374.56
    -8.10 (-0.59%)
     

  • GOLD FUTURES

    2,353.70
    +6.80 (+0.29%)
     

  • RUSSELL 2000

    2,025.23
    +3.22 (+0.16%)
     

  • 10-Yr Bond

    4.2170
    0.0000 (0.00%)
     

  • NASDAQ futures

    20,021.00
    +101.75 (+0.51%)
     

  • VOLATILITY

    12.58
    +0.10 (+0.80%)
     

  • FTSE

    8,231.49
    +26.38 (+0.32%)
     

  • NIKKEI 225

    38,633.02
    +62.26 (+0.16%)
     

  • CAD/EUR

    0.6800
    +0.0013 (+0.19%)
     

Video: Illumina Employees Share Their "Why"

Illumina
·1 min read

NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / What if the work you did every day could impact the lives of people you know? Or all of humanity? At Illumina, we believe that, together, we can use genomics to build a stronger world for the greater good. Regardless of background, department, or job function, a commitment to the mission connects our employees. Meet four professionals working at Illumina and learn what it means to them.

Watch: Share Your Why | Why work at Illumina?

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.

To learn more about working at Illumina, visit our careers site.

ADVERTISEMENT

View additional multimedia and more ESG storytelling from Illumina on 3blmedia.com.

Contact Info:
Spokesperson: Illumina
Website: https://www.3blmedia.com/profiles/illumina
Email: info@3blmedia.com

SOURCE: Illumina



View the original press release on accesswire.com